Petmed Express, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Petmed Express, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Petmed Express, Inc.. The Group's principal activity is to markets prescription and non-prescription pet medications, and other health products for dogs, cats and horses direct to the consumer. It offers an attractive alternative for obtaining pet medications in terms of convenience, price and speed of delivery. The Group's current product line contains approximately 750 skus. These products include a majority of the well-known brands of medication, such as Frontline Plus(R), K9 Advantix(R), Advantage(R), Heartgard Plus(R), Sentinel(R), Interceptor(R), Program(R), Revolution(R), Deramaxx(R) and Rimadyl(R).It markets products through national television, online and direct mail/print advertising campaigns, which aim to increase the recognition of the 1-800-PetMeds brand name, and PetMeds family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers and maximize repeat purchases.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report